A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT07265284 · RECRUITING
Trial details
- NCT number
- NCT07265284
- Sponsor
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2026-09-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.